Clinical

Dataset Information

0

Study of Enzastaurin With 5-Fluorouracil/Leucovorin (5-FU/LV) Plus Bevacizumab as Maintenance Regimen Following First Line Therapy for Metastatic Colon Cancer


ABSTRACT: This study will evaluate the addition of enzastaurin to 5-FU (5-fluorouracil)/LV (leucovorin) plus bevacizumab in the maintenance of best response obtained with 6 cycles of first-line therapy consisting of 5-FU/LV + oxaliplatin (FOLFOX) or 5-FU/LV + irinotecan (FOLFIRI), plus bevacizumab in patients with Metastatic Colorectal Cancer.

DISEASE(S): Locally Advanced Or Metastatic Colorectal Cancer,Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2050435 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2022-02-17 | PXD028899 | Pride
2011-06-24 | E-GEOD-30194 | biostudies-arrayexpress
2011-06-24 | GSE30194 | GEO
| 2624880 | ecrin-mdr-crc
| PRJNA756936 | ENA
| 2029777 | ecrin-mdr-crc
| PRJNA797915 | ENA
| S-EPMC7774735 | biostudies-literature
2019-02-27 | GSE122884 | GEO
2015-06-03 | GSE69494 | GEO